| Xu, Ling |
NCT03986528: Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC) |
|
|
| Recruiting | 4 | 334 | RoW | Kanglaite Injection+Chemotherapy, Chemotherapy | Jie Li, Ministry of Science and Technology of the People´s Republic of China, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences | NSCLC | 03/22 | 05/22 | | |
NCT05229809: Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer |
|
|
| Recruiting | 4 | 212 | RoW | Yiqi Wenyang Jiedu prescription, Simulation agent of Yiqi Wenyang Jiedu prescription | Jie Li | Gastric Carcinoma | 07/23 | 07/24 | | |
NCT05148195: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors |
|
|
| Terminated | 2 | 86 | RoW | Envofolimab, BD0801, Docetaxel, Irinotecan, Leucovorin calcium, 5-Fluorouridine | Jiangsu Simcere Pharmaceutical Co., Ltd. | Advanced Solid Tumor | 07/23 | 07/23 | | |
NCT04848454: Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy |
|
|
| Recruiting | 2 | 30 | RoW | Camrelizumab with vinorelbine and cisplatin | Peking University First Hospital | HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response, Immunotherapy, Vinorelbine, Cisplatin | 02/24 | 12/24 | | |
NCT06354309: Impact of Different Types of Virtual Reality Games on Motion Sickness and Ocular in Adults: A Pilot Study |
|
|
| Completed | N/A | 38 | RoW | Virtual reality game | He Eye Hospital | Amblyopia, Motion Sickness, Dry Eye | 10/23 | 10/23 | | |
| Zhu, Wenwei |
| Recruiting | 1/2 | 80 | RoW | TQB3454 Tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Acute Myeloid Leukemia, Myelodysplastic Syndromes | 06/25 | 12/25 | | |
| Fang, Shengquan |
NCT06696261: A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome |
|
|
| Not yet recruiting | 3 | 342 | RoW | Lianxiaxiaopi Granules, a simulated agent of Lianxiaxiaopi Granules | Tasly Pharmaceutical Group Co., Ltd | Postprandial Distress Syndrome | 06/26 | 08/26 | | |
